BROADCASTS.com

Published: March 6, 2023, 8 a.m.

Stay up-to-date with advances in chronic kidney disease (CKD)! Join our esteemed Chief of Nephrology at Kashlak Memorial Hospital, Dr. Joel Topf, as he leads us through the latest on SGLT2 inhibitors, finerenone, potassium binders, and treatment of CKD-associated metabolic acidosis.
\n
\nClaim free CME for this episode at curbsiders.vcuhealth.org!
\n
\nEpisodes | Subscribe | Spotify | YouTube | Mailing List | askcurbsiders@gmail.com | Swag! | Free CME!
\n
\n
\nShow Segments
\n
\n\n\n

\n
• Intro, disclaimer, guest bio
\n
• Case from Kashlak
\n
• SGLT2i: when to initiate
\n
• SGLT2i: adverse effects
\n
• Finerenone
\n
• Potassium binders
\n
• Treatment of CKD-associated metabolic acidosis\xa0
\n
• Outro
\n

\n\n
\nCredits
\n
\n\n\n

\n
• Writer, Producer, Show Notes, Infographics, and Cover Art: Malini Gandhi
\n
• Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP\xa0 \xa0
\n
• Reviewer: Leah Witt MD
\n
• Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP
\n
• Technical Production: PodPaste
\n
• Guest: Dr. Joel Topf MD
\n

\n\n
\nSponsor: Better Help
\nVisit betterhelp.com/curb today to get 10% off your first month.\xa0
\n
\n
\nSponsor: Birch Living
\nBirch is giving 20% off all mattresses and 2 free eco-rest pillows at birchliving.com/curb.\xa0
\n
\n
\nSponsor: PanaceaFinancial
\n
\nVisit panaceafinancial.com to open a free account.\xa0\n
\n\n
\nFull transcript available HERE
\n
\n
\n\n